These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2242381)

  • 21. The efflux of anthracyclines in multidrug-resistant cell lines.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plasma membrane 'vacuum cleaner' for daunorubicin in non-P-glycoprotein multidrug-resistant SW-1573 human non-small cell lung carcinoma cells. A study using fluorescence resonance energy transfer.
    Mülder HS; van Grondelle R; Westerhoff HV; Lankelma J
    Eur J Biochem; 1993 Dec; 218(3):871-82. PubMed ID: 8281939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor.
    Skovsgaard T
    Cancer Res; 1980 Apr; 40(4):1077-83. PubMed ID: 7357538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-glycoprotein expression in Ehrlich ascites tumour cells after in vitro and in vivo selection with daunorubicin.
    Nielsen D; Eriksen J; Maare C; Jakobsen AH; Skovsgaard T
    Br J Cancer; 1998 Nov; 78(9):1175-80. PubMed ID: 9820176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative P-glycoprotein mediated daunorubicin transport into DNA-loaded plasma membrane vesicles.
    Guiral M; Viratelle O; Westerhoff HV; Lankelma J
    FEBS Lett; 1994 Jun; 346(2-3):141-5. PubMed ID: 7912204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells.
    Spoelstra EC; Westerhoff HV; Dekker H; Lankelma J
    Eur J Biochem; 1992 Jul; 207(2):567-79. PubMed ID: 1353020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.
    Friche E; Skovsgaard T; Nissen NI
    Cancer Chemother Pharmacol; 1987; 19(1):35-9. PubMed ID: 3815723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
    Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
    Mülder HS; Dekker H; Pinedo HM; Lankelma J
    Biochem Pharmacol; 1995 Sep; 50(7):967-74. PubMed ID: 7575681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
    Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
    Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells.
    Versantvoort CH; Broxterman HJ; Lankelma J; Feller N; Pinedo HM
    Biochem Pharmacol; 1994 Sep; 48(6):1129-36. PubMed ID: 7945406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
    Sehested M; Jensen PB; Skovsgaard T; Bindslev N; Demant EJ; Friche E; Vindeløv L
    Br J Cancer; 1989 Dec; 60(6):809-14. PubMed ID: 2605092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
    Hurwitz SJ; Terashima M; Mizunuma N; Slapak CA
    Blood; 1997 May; 89(10):3745-54. PubMed ID: 9160680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin.
    Nagasawa K; Natazuka T; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jan; 19(1):100-5. PubMed ID: 8820920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
    Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
    Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells.
    Ghauharali RI; Westerhoff HV; Dekker H; Lankelma J
    Biochim Biophys Acta; 1996 Jan; 1278(2):213-22. PubMed ID: 8593279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
    Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
    Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH regulation in sensitive and multidrug resistant Ehrlich ascites tumor cells.
    Litman T; Pedersen SF; Kramhøft B; Skovsgaard T; Hoffmann EK
    Cell Physiol Biochem; 1998; 8(3):138-50. PubMed ID: 9617476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.